Literature DB >> 12121912

Methods for data mining from large multinational surveillance studies.

James Poupard1, James Brown, Robert Gagnon, Michael J Stanhope, Chad Stewart.   

Abstract

Traditionally, large surveillance studies have been analyzed by the use of the MICs at which 90% of isolates tested are inhibited (MIC(90)s), MIC(50)s, frequency distributions, and percent susceptibility. In the past, these approaches have proved satisfactory for the monitoring of resistance. From these traditional uses, one can readily detect an increase in MICs for organism and drug combinations. Now that large surveillance studies have been conducted for a number of years and databases have grown to include a large number of datum points, new approaches to the extraction of useful information from these studies are needed. The present study proposes approaches, including the use of antibiotypes, principal components analysis, phylogenetics, and population genetic analysis, to the evaluation of data from large multinational surveillance studies. Application of these types of analyses can be used to describe genetic diversity, analyze changes in susceptibility patterns over time, and possibly, shed light on the origins and evolution of antimicrobial resistance. As global surveillance studies become more common and new questions concerning the evolution of resistance are raised, innovative approaches to analysis of the data will increase in importance.

Mesh:

Substances:

Year:  2002        PMID: 12121912      PMCID: PMC127345          DOI: 10.1128/AAC.46.8.2409-2419.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

Review 1.  Bacterial population genetics, evolution and epidemiology.

Authors:  B G Spratt; M C Maiden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

2.  The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis.

Authors:  E C Holmes; R Urwin; M C Maiden
Journal:  Mol Biol Evol       Date:  1999-06       Impact factor: 16.240

3.  Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences.

Authors:  E J Feil; E C Holmes; D E Bessen; M S Chan; N P Day; M C Enright; R Goldstein; D W Hood; A Kalia; C E Moore; J Zhou; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

4.  Signal, noise, and reliability in molecular phylogenetic analyses.

Authors:  D M Hillis; J P Huelsenbeck
Journal:  J Hered       Date:  1992 May-Jun       Impact factor: 2.645

5.  Relative apparent synapomorphy analysis (RASA). I: The statistical measurement of phylogenetic signal.

Authors:  J Lyons-Weiler; G A Hoelzer; R J Tausch
Journal:  Mol Biol Evol       Date:  1996-07       Impact factor: 16.240

Review 6.  Construction of phylogenetic trees.

Authors:  W M Fitch; E Margoliash
Journal:  Science       Date:  1967-01-20       Impact factor: 47.728

7.  Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996.

Authors:  D Felmingham; J Washington
Journal:  J Chemother       Date:  1999-02       Impact factor: 1.714

8.  A simulation comparison of phylogeny algorithms under equal and unequal evolutionary rates.

Authors:  M K Kuhner; J Felsenstein
Journal:  Mol Biol Evol       Date:  1994-05       Impact factor: 16.240

9.  DNA polymorphism detectable by restriction endonucleases.

Authors:  M Nei; F Tajima
Journal:  Genetics       Date:  1981-01       Impact factor: 4.562

  9 in total
  1 in total

1.  Isolation and identification of nontuberculous mycobacteria from hospitalized patients and drinking water samples--examination of their correlation by chemometrics.

Authors:  Eleni Dovriki; Irini Gerogianni; Efi Petinaki; Christos Hadjichristodoulou; Agelos Papaioannou; Kostas Gourgoulianis
Journal:  Environ Monit Assess       Date:  2016-03-28       Impact factor: 2.513

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.